相似文献
1
Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.
Br J Cancer. 1980 Jun;41(6):886-91. doi: 10.1038/bjc.1980.165.
2
3
Correlations between cell-cycle perturbations and survival levels after exposure to adriamycin for two Chinese hamster cell lines.
Eur J Cancer Clin Oncol. 1983 Apr;19(4):547-51. doi: 10.1016/0277-5379(83)90120-7.
4
The effect of ultrasound on the cytotoxicity of adriamycin.
Br J Radiol. 1990 Jul;63(751):542-6. doi: 10.1259/0007-1285-63-751-542.
5
Effect of different physiological conditions on the action of adriamycin on Chinese hamster cells in vitro.
Br J Cancer. 1981 Aug;44(2):241-6. doi: 10.1038/bjc.1981.175.
6
Comparison of the effects of dihydroxyanthraquinone and adriamycin on the survival of cultured Chinese hamster cells.
Cancer Res. 1982 Sep;42(9):3631-6.
7
8
Adriamycin uptake, intracellular binding and cytotoxicity in Chinese hamster ovary cells.
Cancer Lett. 1985 Sep 15;28(2):213-21. doi: 10.1016/0304-3835(85)90077-1.
9
Enhanced survival of adriamycin-treated Chinese hamster cells by 2-deoxy-D-glucose and 2,4-dinitrophenol.
Cancer Res. 1982 Oct;42(10):3934-40.
10
Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro.
Br J Cancer. 1980 Feb;41(2):277-84. doi: 10.1038/bjc.1980.40.
引用本文的文献
1
Doxorubicin concentrations in bone tumour-relevant tissues after bolus and continuous infusion: a randomized porcine microdialysis study.
Cancer Chemother Pharmacol. 2024 Jun;93(6):555-564. doi: 10.1007/s00280-023-04637-1. Epub 2024 Feb 8.
2
Mathematical models of tumor cell proliferation: A review of the literature.
Expert Rev Anticancer Ther. 2018 Dec;18(12):1271-1286. doi: 10.1080/14737140.2018.1527689. Epub 2018 Oct 22.
3
A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer.
Sci Rep. 2017 Jul 18;7(1):5725. doi: 10.1038/s41598-017-05902-z.
4
A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin.
J Pharm Sci. 2015 Dec;104(12):4409-4416. doi: 10.1002/jps.24631. Epub 2015 Sep 7.
5
Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: Implications in topical drug delivery in the eye.
Mol Vis. 2011;17:2507-15. Epub 2011 Sep 27.
6
Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization.
J Am Chem Soc. 2011 Jun 22;133(24):9242-5. doi: 10.1021/ja203286n. Epub 2011 May 31.
7
Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.
AAPS J. 2008;10(1):15-34. doi: 10.1208/s12248-007-9003-6. Epub 2008 Feb 5.
8
Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin.
Neoplasia. 2005 Jul;7(7):705-13. doi: 10.1593/neo.05118.
9
Adaptive control methods for the dose individualisation of anticancer agents.
Clin Pharmacokinet. 2000 Apr;38(4):315-53. doi: 10.2165/00003088-200038040-00003.
10
The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells.
Br J Cancer. 1999 Feb;79(5-6):838-42. doi: 10.1038/sj.bjc.6690134.
本文引用的文献
1
Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro.
Br J Cancer. 1980 Feb;41(2):277-84. doi: 10.1038/bjc.1980.40.
2
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.
Cancer Chemother Rep. 1970 Dec;54(6):431-50.
3
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.
Cancer. 1974 Jan;33(1):19-27. doi: 10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-m.
4
Survival and cell kinetics effects of adriamycin on mammalian cells.
Cancer Res. 1973 Jan;33(1):11-6.
5
Survival kinetics of cultured human lymphoma cells exposed to adriamycin.
Cancer Res. 1973 Jun;33(6):1141-5.
6
A fluorometric assay for daunomycin and adriamycin in animal tissues.
Biochem Med. 1973 Jun;7(3):396-404. doi: 10.1016/0006-2944(73)90060-4.
7
Adriamycin-a review.
J Natl Cancer Inst. 1975 Dec;55(6):1265-74. doi: 10.1093/jnci/55.6.1265.
8
Clinical effects and pharmacokinetics of different dosage schedules of adriamycin.
Cancer Res. 1976 Jan;36(1):216-21.
9
The concept of drug dose for in vitro studies with chemotherapeutic agents.
Radiat Res. 1978 Dec;76(3):441-58.
10
Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
Cancer Treat Rep. 1978 May;62(5):791-800.
Zotero 插件